世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
ブレストイメージング市場。技術別（イオン化技術、非イオン化技術）、エンドユーザー別（病院・診療所、専門施設）、地域別（北米、欧州、アジア太平洋、その他の地域）の情報-2027年までの予測Breast Imaging Market: Information by Technology (Ionizing and Non-Ionizing Technology), by End User (Hospitals & Clinics and Specialty Centers), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)Forecast till 2027 Breast Imaging Market—Forecast till 2027 Breast imaging Market Forecast The breast imaging market is exceeded cross USD 6,810.80 million by 2027 to register a healthy CAGR of 8.38%. Breast imag... もっと見る
サマリーBreast Imaging Market—Forecast till 2027Breast imaging Market Forecast The breast imaging market is exceeded cross USD 6,810.80 million by 2027 to register a healthy CAGR of 8.38%. Breast imaging is a sub-strength of analytic radiology that includes imaging the breasts for screening or demonstrative purposes. The development of the worldwide breast imaging market is driven by the elements like the rising predominance of breast disease, expanding commonness of the early location of tumors. Furthermore, the developing market for breast imaging sets out rewarding freedom for the market. Nonetheless, the related danger from radiation openness is probably going to limit the market development. Breast imaging is a sub-division to the fame of symptomatic radiology that includes imaging the bosoms for screening or analytic purposes. The development of the worldwide breast imaging market is driven by the variables like the rising commonness of bosom malignancy, expanding pervasiveness of early location of diseases. Additionally, the developing business sector for breast imaging sets out rewarding freedom for the market. Besides, the related danger from radiation exposure is probably going to limit the market development. Segment Overview The global Breast imaging market has been classified into technology and end-user. In terms of technology type, the global market has been classified into ionizing technology, non-ionizing technology, and others. The Ionizing technology segment is further classified into Mammography, molecular breast imaging (MBI) or Molecular breast-specific Gamma Imaging (BSGI), PET-CT, Contrast-Enhanced Spectral Mammography (CESM), and Cone-Beam Computed Tomography. The Non-Ionizing Technology segment is further classified into Breast ultrasound, Breast MRI, Breast Thermography, Optical Imaging, Microwave Imaging, Electrical Impedance Imaging (EII), and Others. Based on the end-use segment the global breast imaging market has been divided into Hospitals and clinics, specialty centers, and others. Regional market North America ruled the worldwide breast malignancy imaging market inferable from different factors like the high pervasiveness of breast disease among ladies, rising mindfulness about breast disease, innovative progressions, and the presence of significant makers in the area. Breast malignancy patients are expanding in the US and Canada. It is the most normal malignancy found in American ladies, and the normal danger of creating breast disease in ladies in the US is around 13% in their life. As indicated by the American Cancer Society, it is assessed that for breast disease in the United States in 2021, around 281,550 new instances of obtrusive breast malignancy will be analyzed in ladies, around 49,290 new instances of ductal carcinoma in situ (DCIS) will be analyzed, and around 43,600 ladies will pass on from breast disease. As indicated by the Canadian Cancer Society, in 2019, breast malignancy was the subsequent driving reason for death from disease in Canadian ladies. Europe likewise has developed as an unmistakable market for breast imaging with an expanding commonness of breast cancer and grounded medical services foundation. Key Competitors The major players operating in the global Breast imaging market are Koninklijke Philips NV (Netherlands), General Electric Company (US), Siemens (Germany), Fujifilm Holdings Corporation (Japan), Hologic, Inc. (US), Delphinus Medical Technologies, Inc. (US), SonoCiné (US), CMR , aviscan Corporation (US), Planmed Oy (Finland), and KUB Technologies (US). COVID 19 Impacts We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights. 目次LIST OF CONTENTS1 EXECUTIVE SUMMARY 14 2 MARKET INTRODUCTION 15 2.1 SCOPE OF THE STUDY 15 2.2 RESEARCH OBJECTIVE 15 2.3 MARKET STRUCTURE 15 2.4 ASSUMPTIONS & LIMITATIONS 16 3 RESEARCH METHODOLOGY 17 3.1 DATA MINING 17 3.2 SECONDARY RESEARCH 18 3.3 PRIMARY RESEARCH 18 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 19 3.5 FORECASTING TECHNIQUES 20 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21 3.6.1 BOTTOM-UP APPROACH 21 3.6.2 TOP-DOWN APPROACH 22 3.7 DATA TRIANGULATION 22 3.8 VALIDATION 23 4 MARKET DYNAMICS 24 4.1 OVERVIEW 24 4.2 DRIVERS 25 4.2.1 RISING PREVALENCE OF BREAST CANCER 25 4.2.2 INCREASING AWARENESS FOR EARLY DETECTION OF BREAST CANCER 25 4.2.3 RISING R&D INVESTMENT FOR BREAST CANCER 25 4.2.4 GROWING GERIATRIC POPULATION 26 4.3 RESTRAINTS 27 4.3.1 ASSOCIATED RISKS FROM RADIATION EXPOSURE 27 4.4 OPPORTUNITIES 28 4.4.1 EMERGING MARKETS OF BREAST IMAGING 28 4.4.2 TECHNOLOGICAL ADVANCEMENTS 28 5 MARKET FACTOR ANALYSIS 29 5.1 VALUE CHAIN ANALYSIS 29 5.1.1 R&D 30 5.1.2 MANUFACTURING 30 5.1.3 DISTRIBUTION AND SALES 30 5.1.4 POST-SALES MONITORING 30 5.2 PORTER'S FIVE FORCES MODEL 31 5.2.1 BARGAINING POWER OF SUPPLIERS 31 5.2.2 BARGAINING POWER OF BUYERS 31 5.2.3 THREAT OF NEW ENTRANTS 32 5.2.4 THREAT OF SUBSTITUTES 32 5.2.5 INTENSITY OF RIVALRY 32 5.3 IMPACT OF COVID-19 ON THE BREAST IMAGING MARKET 32 5.3.1 IMPACT ON DEMAND 32 5.3.2 IMPACT ON GROWTH 33 5.3.3 IMPACT ON GDP 33 5.3.4 IMPACT ON SUPPLY CHAIN 33 6 GLOBAL BREAST IMAGING MARKET, BY TECHNOLOGY 34 6.1 OVERVIEW 34 6.2 IONIZING TECHNOLOGY 36 6.2.1 MAMMOGRAPHY 37 6.2.1.1 DIGITAL MAMMOGRAPHY 38 6.2.1.2 3D MAMMOGRAM/3D BREAST TOMOSYNTHESIS 39 6.2.1.3 POSITRON EMISSION MAMMOGRAPHY(PEM) 39 6.2.1.4 ANALOG MAMMOGRAPHY 39 6.2.2 MOLECULAR BREAST IMAGING (MBI) 40 6.2.3 PET-CT 40 6.2.4 CONTRAST ENHANCED SPECTRAL MAMMOGRAPHY (CESM) 40 6.2.5 CONE-BEAM COMPUTED TOMOGRAPHY 41 6.3 NON-IONIZING TECHNOLOGY 41 6.3.1 BREAST ULTRASOUND 43 6.3.2 BREAST MRI 43 6.3.3 BREAST THERMOGRAPHY 43 6.3.4 MICROWAVE IMAGING 44 6.3.5 OPTICAL IMAGING 44 6.3.6 ELECTRIC IMPEDENCE IMAGING (EII) 44 6.4 OTHERS 45 7 GLOBAL BREAST IMAGING MARKET, BY END USER 46 7.1 OVERVIEW 46 7.2 HOSPITALS & CLINICS 47 7.3 SPECIALTY CENTERS 47 7.4 OTHERS 48 8 GLOBAL BREAST IMAGING MARKET, BY REGION 49 8.1 OVERVIEW 49 8.2 NORTH AMERICA 51 8.2.1 US 54 8.2.2 CANADA 56 8.3 EUROPE 58 8.3.1 GERMANY 61 8.3.2 FRANCE 63 8.3.3 UK 65 8.3.4 ITALY 67 8.3.5 SPAIN 69 8.3.6 REST OF EUROPE 71 8.4 ASIA-PACIFIC 73 8.4.1 CHINA 76 8.4.2 INDIA 78 8.4.3 JAPAN 80 8.4.4 SOUTH KOREA 82 8.4.5 AUSTRALIA 84 8.4.6 REST OF ASIA-PACIFIC 86 8.5 REST OF THE WORLD 89 8.5.1 MIDDLE EAST 92 8.5.2 AFRICA 94 8.5.3 LATIN AMERICA 96 9 COMPETITIVE LANDSCAPE 98 9.1 OVERVIEW 98 9.2 COMPETITIVE BENCHMARKING 99 9.3 MAJOR GROWTH STRATEGY IN THE BREAST IMAGING MARKET 100 9.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE BREAST IMAGING MARKET 101 9.5 KEY DEVELOPMENT ANALYSIS 101 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 102 9.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL 102 9.6.2 MERGER/ ACQUISITION 103 9.6.3 EXPANSION/ INVESTMENT 103 9.7 FINANCIAL MATRIX 104 9.7.1 SALES, 2020 104 9.7.2 R&D EXPENDITURE 104 10 COMPANY PROFILES 105 10.1 KONINKLIJKE PHILIPS N.V. 105 10.1.1 COMPANY OVERVIEWS 105 10.1.2 FINANCIAL OVERVIEW 106 10.1.3 PRODUCTS/SERVICES OFFERED 107 10.1.4 KEY DEVELOPMENTS 107 10.1.5 SWOT ANALYSIS 108 10.1.6 KEY STRATEGIES 108 10.2 GENERAL ELECTRIC COMPANY 109 10.2.1 COMPANY OVERVIEW 109 10.2.2 FINANCIAL OVERVIEW 109 10.2.3 PRODUCTS/SERVICES OFFERED 110 10.2.4 KEY DEVELOPMENTS 110 10.2.5 SWOT ANALYSIS 111 10.2.6 KEY STRATEGIES 111 10.3 SIEMENS (SIEMENS HEALTHCARE GMBH) 112 10.3.1 COMPANY OVERVIEWS 112 10.3.2 FINANCIAL OVERVIEW 112 10.3.3 PRODUCTS/SERVICES OFFERED 113 10.3.4 KEY DEVELOPMENTS 113 10.3.5 SWOT ANALYSIS 114 10.3.6 KEY STRATEGIES 114 10.4 FUJIFILM HOLDINGS CORPORATION. 115 10.4.1 COMPANY OVERVIEWS 115 10.4.2 FINANCIAL OVERVIEW 115 10.4.3 PRODUCTS/SERVICES OFFERED 116 10.4.4 KEY DEVELOPMENTS 116 10.4.5 SWOT ANALYSIS 117 10.4.6 KEY STRATEGIES 117 10.5 HOLOGIC, INC. 118 10.5.1 COMPANY OVERVIEWS 118 10.5.2 FINANCIAL OVERVIEW 118 10.5.3 PRODUCTS/SERVICES OFFERED 119 10.5.4 KEY DEVELOPMENTS 119 10.5.5 SWOT ANALYSIS 120 10.5.6 KEY STRATEGIES 120 10.6 DELPHINUS MEDICAL TECHNOLOGIES, INC. 121 10.6.1 COMPANY OVERVIEW 121 10.6.2 FINANCIAL OVERVIEW 121 10.6.3 PRODUCTS/SERVICES OFFERED 121 10.6.4 KEY DEVELOPMENTS 121 10.6.5 SWOT ANALYSIS 122 10.6.6 KEY STRATEGIES 122 10.7 SONOCINÉ 123 10.7.1 COMPANY OVERVIEW 123 10.7.2 FINANCIAL OVERVIEW 123 10.7.3 PRODUCTS/SERVICES OFFERED 123 10.7.4 KEY DEVELOPMENTS 123 10.7.5 SWOT ANALYSIS 124 10.7.6 KEY STRATEGIES 124 10.8 CMR NAVISCAN CORPORATION 125 10.8.1 COMPANY OVERVIEW 125 10.8.2 FINANCIAL OVERVIEW 125 10.8.3 PRODUCTS/SERVICES OFFERED 125 10.8.4 KEY DEVELOPMENTS 125 10.8.5 SWOT ANALYSIS 126 10.8.6 KEY STRATEGIES 126 10.9 PLANMED OY 127 10.9.1 COMPANY OVERVIEWS 127 10.9.2 FINANCIAL OVERVIEW 127 10.9.3 PRODUCTS/SERVICES OFFERED 127 10.9.4 KEY DEVELOPMENTS 127 10.9.5 SWOT ANALYSIS 128 10.9.6 KEY STRATEGIES 128 10.10 KUB TECHNOLOGIES 129 10.10.1 COMPANY OVERVIEWS 129 10.10.2 FINANCIAL OVERVIEW 129 10.10.3 PRODUCTS/SERVICES OFFERED 129 10.10.4 KEY DEVELOPMENTS 129 10.10.5 SWOT ANALYSIS 130 10.10.6 KEY STRATEGIES 130 11 APPENDIX 131 11.1 REFERENCES 131 11.2 RELATED REPORTS 131
SummaryBreast Imaging Market—Forecast till 2027Breast imaging Market Forecast The breast imaging market is exceeded cross USD 6,810.80 million by 2027 to register a healthy CAGR of 8.38%. Breast imaging is a sub-strength of analytic radiology that includes imaging the breasts for screening or demonstrative purposes. The development of the worldwide breast imaging market is driven by the elements like the rising predominance of breast disease, expanding commonness of the early location of tumors. Furthermore, the developing market for breast imaging sets out rewarding freedom for the market. Nonetheless, the related danger from radiation openness is probably going to limit the market development. Breast imaging is a sub-division to the fame of symptomatic radiology that includes imaging the bosoms for screening or analytic purposes. The development of the worldwide breast imaging market is driven by the variables like the rising commonness of bosom malignancy, expanding pervasiveness of early location of diseases. Additionally, the developing business sector for breast imaging sets out rewarding freedom for the market. Besides, the related danger from radiation exposure is probably going to limit the market development. Segment Overview The global Breast imaging market has been classified into technology and end-user. In terms of technology type, the global market has been classified into ionizing technology, non-ionizing technology, and others. The Ionizing technology segment is further classified into Mammography, molecular breast imaging (MBI) or Molecular breast-specific Gamma Imaging (BSGI), PET-CT, Contrast-Enhanced Spectral Mammography (CESM), and Cone-Beam Computed Tomography. The Non-Ionizing Technology segment is further classified into Breast ultrasound, Breast MRI, Breast Thermography, Optical Imaging, Microwave Imaging, Electrical Impedance Imaging (EII), and Others. Based on the end-use segment the global breast imaging market has been divided into Hospitals and clinics, specialty centers, and others. Regional market North America ruled the worldwide breast malignancy imaging market inferable from different factors like the high pervasiveness of breast disease among ladies, rising mindfulness about breast disease, innovative progressions, and the presence of significant makers in the area. Breast malignancy patients are expanding in the US and Canada. It is the most normal malignancy found in American ladies, and the normal danger of creating breast disease in ladies in the US is around 13% in their life. As indicated by the American Cancer Society, it is assessed that for breast disease in the United States in 2021, around 281,550 new instances of obtrusive breast malignancy will be analyzed in ladies, around 49,290 new instances of ductal carcinoma in situ (DCIS) will be analyzed, and around 43,600 ladies will pass on from breast disease. As indicated by the Canadian Cancer Society, in 2019, breast malignancy was the subsequent driving reason for death from disease in Canadian ladies. Europe likewise has developed as an unmistakable market for breast imaging with an expanding commonness of breast cancer and grounded medical services foundation. Key Competitors The major players operating in the global Breast imaging market are Koninklijke Philips NV (Netherlands), General Electric Company (US), Siemens (Germany), Fujifilm Holdings Corporation (Japan), Hologic, Inc. (US), Delphinus Medical Technologies, Inc. (US), SonoCiné (US), CMR , aviscan Corporation (US), Planmed Oy (Finland), and KUB Technologies (US). COVID 19 Impacts We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights. Table of ContentsLIST OF CONTENTS1 EXECUTIVE SUMMARY 14 2 MARKET INTRODUCTION 15 2.1 SCOPE OF THE STUDY 15 2.2 RESEARCH OBJECTIVE 15 2.3 MARKET STRUCTURE 15 2.4 ASSUMPTIONS & LIMITATIONS 16 3 RESEARCH METHODOLOGY 17 3.1 DATA MINING 17 3.2 SECONDARY RESEARCH 18 3.3 PRIMARY RESEARCH 18 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 19 3.5 FORECASTING TECHNIQUES 20 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21 3.6.1 BOTTOM-UP APPROACH 21 3.6.2 TOP-DOWN APPROACH 22 3.7 DATA TRIANGULATION 22 3.8 VALIDATION 23 4 MARKET DYNAMICS 24 4.1 OVERVIEW 24 4.2 DRIVERS 25 4.2.1 RISING PREVALENCE OF BREAST CANCER 25 4.2.2 INCREASING AWARENESS FOR EARLY DETECTION OF BREAST CANCER 25 4.2.3 RISING R&D INVESTMENT FOR BREAST CANCER 25 4.2.4 GROWING GERIATRIC POPULATION 26 4.3 RESTRAINTS 27 4.3.1 ASSOCIATED RISKS FROM RADIATION EXPOSURE 27 4.4 OPPORTUNITIES 28 4.4.1 EMERGING MARKETS OF BREAST IMAGING 28 4.4.2 TECHNOLOGICAL ADVANCEMENTS 28 5 MARKET FACTOR ANALYSIS 29 5.1 VALUE CHAIN ANALYSIS 29 5.1.1 R&D 30 5.1.2 MANUFACTURING 30 5.1.3 DISTRIBUTION AND SALES 30 5.1.4 POST-SALES MONITORING 30 5.2 PORTER'S FIVE FORCES MODEL 31 5.2.1 BARGAINING POWER OF SUPPLIERS 31 5.2.2 BARGAINING POWER OF BUYERS 31 5.2.3 THREAT OF NEW ENTRANTS 32 5.2.4 THREAT OF SUBSTITUTES 32 5.2.5 INTENSITY OF RIVALRY 32 5.3 IMPACT OF COVID-19 ON THE BREAST IMAGING MARKET 32 5.3.1 IMPACT ON DEMAND 32 5.3.2 IMPACT ON GROWTH 33 5.3.3 IMPACT ON GDP 33 5.3.4 IMPACT ON SUPPLY CHAIN 33 6 GLOBAL BREAST IMAGING MARKET, BY TECHNOLOGY 34 6.1 OVERVIEW 34 6.2 IONIZING TECHNOLOGY 36 6.2.1 MAMMOGRAPHY 37 6.2.1.1 DIGITAL MAMMOGRAPHY 38 6.2.1.2 3D MAMMOGRAM/3D BREAST TOMOSYNTHESIS 39 6.2.1.3 POSITRON EMISSION MAMMOGRAPHY(PEM) 39 6.2.1.4 ANALOG MAMMOGRAPHY 39 6.2.2 MOLECULAR BREAST IMAGING (MBI) 40 6.2.3 PET-CT 40 6.2.4 CONTRAST ENHANCED SPECTRAL MAMMOGRAPHY (CESM) 40 6.2.5 CONE-BEAM COMPUTED TOMOGRAPHY 41 6.3 NON-IONIZING TECHNOLOGY 41 6.3.1 BREAST ULTRASOUND 43 6.3.2 BREAST MRI 43 6.3.3 BREAST THERMOGRAPHY 43 6.3.4 MICROWAVE IMAGING 44 6.3.5 OPTICAL IMAGING 44 6.3.6 ELECTRIC IMPEDENCE IMAGING (EII) 44 6.4 OTHERS 45 7 GLOBAL BREAST IMAGING MARKET, BY END USER 46 7.1 OVERVIEW 46 7.2 HOSPITALS & CLINICS 47 7.3 SPECIALTY CENTERS 47 7.4 OTHERS 48 8 GLOBAL BREAST IMAGING MARKET, BY REGION 49 8.1 OVERVIEW 49 8.2 NORTH AMERICA 51 8.2.1 US 54 8.2.2 CANADA 56 8.3 EUROPE 58 8.3.1 GERMANY 61 8.3.2 FRANCE 63 8.3.3 UK 65 8.3.4 ITALY 67 8.3.5 SPAIN 69 8.3.6 REST OF EUROPE 71 8.4 ASIA-PACIFIC 73 8.4.1 CHINA 76 8.4.2 INDIA 78 8.4.3 JAPAN 80 8.4.4 SOUTH KOREA 82 8.4.5 AUSTRALIA 84 8.4.6 REST OF ASIA-PACIFIC 86 8.5 REST OF THE WORLD 89 8.5.1 MIDDLE EAST 92 8.5.2 AFRICA 94 8.5.3 LATIN AMERICA 96 9 COMPETITIVE LANDSCAPE 98 9.1 OVERVIEW 98 9.2 COMPETITIVE BENCHMARKING 99 9.3 MAJOR GROWTH STRATEGY IN THE BREAST IMAGING MARKET 100 9.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE BREAST IMAGING MARKET 101 9.5 KEY DEVELOPMENT ANALYSIS 101 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 102 9.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL 102 9.6.2 MERGER/ ACQUISITION 103 9.6.3 EXPANSION/ INVESTMENT 103 9.7 FINANCIAL MATRIX 104 9.7.1 SALES, 2020 104 9.7.2 R&D EXPENDITURE 104 10 COMPANY PROFILES 105 10.1 KONINKLIJKE PHILIPS N.V. 105 10.1.1 COMPANY OVERVIEWS 105 10.1.2 FINANCIAL OVERVIEW 106 10.1.3 PRODUCTS/SERVICES OFFERED 107 10.1.4 KEY DEVELOPMENTS 107 10.1.5 SWOT ANALYSIS 108 10.1.6 KEY STRATEGIES 108 10.2 GENERAL ELECTRIC COMPANY 109 10.2.1 COMPANY OVERVIEW 109 10.2.2 FINANCIAL OVERVIEW 109 10.2.3 PRODUCTS/SERVICES OFFERED 110 10.2.4 KEY DEVELOPMENTS 110 10.2.5 SWOT ANALYSIS 111 10.2.6 KEY STRATEGIES 111 10.3 SIEMENS (SIEMENS HEALTHCARE GMBH) 112 10.3.1 COMPANY OVERVIEWS 112 10.3.2 FINANCIAL OVERVIEW 112 10.3.3 PRODUCTS/SERVICES OFFERED 113 10.3.4 KEY DEVELOPMENTS 113 10.3.5 SWOT ANALYSIS 114 10.3.6 KEY STRATEGIES 114 10.4 FUJIFILM HOLDINGS CORPORATION. 115 10.4.1 COMPANY OVERVIEWS 115 10.4.2 FINANCIAL OVERVIEW 115 10.4.3 PRODUCTS/SERVICES OFFERED 116 10.4.4 KEY DEVELOPMENTS 116 10.4.5 SWOT ANALYSIS 117 10.4.6 KEY STRATEGIES 117 10.5 HOLOGIC, INC. 118 10.5.1 COMPANY OVERVIEWS 118 10.5.2 FINANCIAL OVERVIEW 118 10.5.3 PRODUCTS/SERVICES OFFERED 119 10.5.4 KEY DEVELOPMENTS 119 10.5.5 SWOT ANALYSIS 120 10.5.6 KEY STRATEGIES 120 10.6 DELPHINUS MEDICAL TECHNOLOGIES, INC. 121 10.6.1 COMPANY OVERVIEW 121 10.6.2 FINANCIAL OVERVIEW 121 10.6.3 PRODUCTS/SERVICES OFFERED 121 10.6.4 KEY DEVELOPMENTS 121 10.6.5 SWOT ANALYSIS 122 10.6.6 KEY STRATEGIES 122 10.7 SONOCINÉ 123 10.7.1 COMPANY OVERVIEW 123 10.7.2 FINANCIAL OVERVIEW 123 10.7.3 PRODUCTS/SERVICES OFFERED 123 10.7.4 KEY DEVELOPMENTS 123 10.7.5 SWOT ANALYSIS 124 10.7.6 KEY STRATEGIES 124 10.8 CMR NAVISCAN CORPORATION 125 10.8.1 COMPANY OVERVIEW 125 10.8.2 FINANCIAL OVERVIEW 125 10.8.3 PRODUCTS/SERVICES OFFERED 125 10.8.4 KEY DEVELOPMENTS 125 10.8.5 SWOT ANALYSIS 126 10.8.6 KEY STRATEGIES 126 10.9 PLANMED OY 127 10.9.1 COMPANY OVERVIEWS 127 10.9.2 FINANCIAL OVERVIEW 127 10.9.3 PRODUCTS/SERVICES OFFERED 127 10.9.4 KEY DEVELOPMENTS 127 10.9.5 SWOT ANALYSIS 128 10.9.6 KEY STRATEGIES 128 10.10 KUB TECHNOLOGIES 129 10.10.1 COMPANY OVERVIEWS 129 10.10.2 FINANCIAL OVERVIEW 129 10.10.3 PRODUCTS/SERVICES OFFERED 129 10.10.4 KEY DEVELOPMENTS 129 10.10.5 SWOT ANALYSIS 130 10.10.6 KEY STRATEGIES 130 11 APPENDIX 131 11.1 REFERENCES 131 11.2 RELATED REPORTS 131
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
Market Research Future 社の最新刊レポート
本レポートと同じKEY WORD（）の最新刊レポート
よくあるご質問Market Research Future社はどのような調査会社ですか?マーケットリサーチフューチャー（Market Research Future）は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。 下記分野については、分野毎に専... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/04 10:27 147.72 円 163.39 円 196.69 円 |